Last reviewed · How we verify
Other combined oral contraceptives
Other combined oral contraceptives is a Small molecule drug developed by Bayer. It is currently in Phase 2 development.
At a glance
| Generic name | Other combined oral contraceptives |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants (PHASE1)
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
- A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults (PHASE1)
- Effects of Intermittent Fasting on Polycystic Ovary Syndrome (PCOS) Compared to Standard Treatment (NA)
- Evaluating Household Visits and Small Groups to Increase Contraception Use Among Married Adolescent Girls in Rural Niger (NA)
- Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders (PHASE3)
- Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women (PHASE2)
- A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Other combined oral contraceptives CI brief — competitive landscape report
- Other combined oral contraceptives updates RSS · CI watch RSS
- Bayer portfolio CI
Frequently asked questions about Other combined oral contraceptives
What is Other combined oral contraceptives?
Other combined oral contraceptives is a Small molecule drug developed by Bayer.
Who makes Other combined oral contraceptives?
Other combined oral contraceptives is developed by Bayer (see full Bayer pipeline at /company/bayer).
What development phase is Other combined oral contraceptives in?
Other combined oral contraceptives is in Phase 2.
Related
- Manufacturer: Bayer — full pipeline
- Compare: Other combined oral contraceptives vs similar drugs
- Pricing: Other combined oral contraceptives cost, discount & access